To ask Her Majesty's Government what involvement the vaccine industry will have in discussions with the NHS Chief Executive when reviewing incentives, including payment by results, to accelerate the uptake of medical technologies. [HL5262]

The life sciences industry, which includes the pharmaceutical sector, was involved in the development of the Life Sciences Blueprint published on 14 July 2009. As a major stakeholder, the industry will continue to be involved in the implementation of the proposals in the blueprint.